NCT01145235已完成不适用
Swedish Macrolane Registry
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Galderma R&D
- 入组人数
- 1,300
- 试验地点
- 1
- 主要终点
- To document the incidence of breast cancer in female subjects after treatment with Macrolane VRFs in the breasts when the product is used in clinical practice.
研究概览
简要总结
A Registry to monitor long term safety in female subjects after treatment with Macrolane VRF20 and/or MacrolaneT VRF30 in the breasts.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Females previously treated with Macrolane VRF in the breasts
- •Females continuously being treated with Macrolane VRF in the breasts, initial treatment or re-treatment.
排除标准
- •No exclusion criteria
结局指标
主要结局
To document the incidence of breast cancer in female subjects after treatment with Macrolane VRFs in the breasts when the product is used in clinical practice.
时间窗: 2010-2015
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
撤回
不适用
Macrolane Prospective SurveyFemales Recently Treated With Macrolane VRF in the BreastsNCT01223066Galderma R&D
已完成
2 期
Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple SclerosisRelapsing Multiple SclerosisNCT03996291Sanofi125
已完成
3 期
Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of DyspepsiaDyspepsiaNCT00232037Novartis359
已完成
3 期
Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of DyspepsiaDyspepsiaNCT00232102Novartis423
进行中（未招募）
不适用
Long Term Follow-Up for Safety of AVR-RD-02Gaucher DiseaseNCT06488261John Bernat2